Europe Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and Clinics,

Europe Botulinum Toxin Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Botulinum toxin A and Botulinum toxin B), Application (Medical and Aesthetic), and End User (Speciality and Dermatology Clinics, Hospitals and Clinics, and Others)

The Europe botulinum toxin market is expected to reach US$ 2,204.0 million by 2028 from US$ 1,286.6 million in 2021. The market is estimated to grow at a CAGR of 8.0% from 2021 to 2028.

In recent years, non-invasive cosmetic treatments have gained substantial popularity due to minimal downtime, no scarring, low cost, greater accuracy, and fewer complications compared to open procedures. In addition, non-invasive treatments are gaining importance due to lower post-treatment downtime.

European countries are taking several initiatives to raise awareness about non-invasive aesthetic procedures. For instance, in 2019, government authorities in England launched a campaign about botched cosmetic procedures and their impact on a person's physical and mental health. Moreover, several manufacturers are working on offering more advanced non-invasive cosmetic treatment products. Therefore, the rising awareness about non-invasive cosmetic procedures and the increasing availability of user-friendly and technologically-advanced non-invasive cosmetic treatment products are boosting the Europe botulinum toxin market.

With these new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the botulinum toxin market at a healthy CAGR during the forecast period.

Europe Botulinum Toxin Market Revenue and Forecast to 2028 (US$ Million)

Europe Botulinum Toxin Market Segmentation

By Product Type

Type A Botulinum Toxin Type B Botulinum Toxin By Application

Medical Chronic Migraine Muscle Spasm Over Reactive Bladder Hyperhidrosis Others Aesthetic Crow's Feet Forehead Lines Frown Lines/ Glabellar Square Jaw/ Masseter Others By End-User

Specialty And Dermatology Clinics Hospitals And Clinics Others By Country

Europe Germany UKFrance Spain Italy Rest of Europe Companies Mentioned

Abb Vie Inc.Merz Pharma Medytox Sanofi Ipsen Pharma Galderma Candela Medical

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe botulinum toxin market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe botulinum toxin market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.